IDiyas

For the Inventor, By the Inventor

Brussels, Belgium

David Craig McGowan

USPTO Granted Patents = 61 

Average Co-Inventor Count = 4.8

ph-index = 11

Forward Citations = 374(Granted Patents)


Inventors with similar research interests:


Location History:

  • Arlington, MA (US) (2008)
  • Woluwe St. Pierre, BE (2008 - 2010)
  • Woluwe Street Pierre, BE (2010)
  • Brussel, BE (2014 - 2019)
  • Brussels, BE (2011 - 2024)

Company Filing History:

goldMedal23 out of 111 
 
Janssen Sciences Ireland Uc
 patents
silverMedal13 out of 60 
 
Janssen Sciences Ireland Unlimited Company
 patents
bronzeMedal10 out of 34 
 
Aligos Therapeutics, Inc.
 patents
4. 8 out of 1,970 
 
Amgen Inc.
 patents
5. 5 out of 45 
 
Janssen R&d Ireland
 patents
6. 1 out of 66 
 
Tibotec Pharmaceuticals Ltd.
 patents
7. 1 out of 1 
 
Janssen Research & Development Ireland
 patent
8. 1 out of 120 
 
Medivir Ab
 patents
where one patent can have more than one assignee

Years Active: 2008-2024

Loading Chart...
61 patents (USPTO):
1. 12180192 - Modulators of THR-β and methods of use thereof (2024-12-31),
2. 12018015 - Methods and compositions for targeting PD-L1 (2024-06-25),
3. 11957683 - Bicyclic compounds (2024-04-16),
4. 11952374 - Bicyclic compounds (2024-04-09),
5. 11858913 - Bicyclic pyridazinones and methods of use thereof (2024-01-02),
6. 11840532 - Modulators of THR-β and methods of use thereof (2023-12-12),
7. 11793815 - Oxindoles and methods of use thereof (2023-10-24),
8. 11786532 - 2-pyridones and methods of use thereof (2023-10-17),
9. 11220504 - Pyrrolo[3,2-d] pyrimidine derivatives for the treatment of viral infections and other diseases (2022-01-11),
10. 11198699 - Compounds targeting PRMT5 (2021-12-14),
11. 11117887 - Aryl substituted pyrimidines for use in influenza virus infection (2021-09-14),
12. 11104678 - Purine derivatives for the treatment of viral infections (2021-08-31),
13. 11091467 - Modulators of THR-β and methods of use thereof (2021-08-17),
14. 11053256 - Dihydropyranopyrimidines for the treatment of viral infections (2021-07-06),
15. 10968184 - Pyrimidine prodrugs for the treatment of viral infections and further diseases (2021-04-06),

As an AI assistant specialized in innovations, inventions, inventors, patent attorneys, assignees, and patents, I am pleased to provide you with an article on the renowned inventor David Craig McGowan.

Title: The Innovative Legacy of David Craig McGowan

Introduction:

David Craig McGowan, a distinguished inventor based in Brussels, BE, has made significant contributions to the field of pharmaceuticals with his inventive spirit and numerous patented inventions.

Latest Patents:

With an impressive total of 59 patents to his name, David's latest patents focus on bicyclic compounds. These compounds, represented by Formula (I) or their pharmaceutically acceptable salts, have paved the way for novel pharmaceutical compositions and methods of treating various diseases and conditions.

Career Highlights:

David Craig McGowan has left a mark in the industry through his work with prominent companies such as Janssen Sciences Ireland Uc and Janssen Sciences Ireland Unlimited Company. His dedication to innovation and excellence is evident in the groundbreaking patents he has successfully obtained over the years.

Collaborations:

Throughout his career, David has had the privilege of collaborating with esteemed professionals in the field. Notable coworkers include Pierre Jean-Marie Bernard Raboisson and Tim Hugo Maria Jonckers, who have shared in his passion for driving innovation forward.

Conclusion:

In conclusion, David Craig McGowan's exceptional talent and relentless pursuit of innovation have solidified his position as a leading inventor in the pharmaceutical sector. His patented inventions continue to inspire advancements in the industry, leaving a lasting legacy for future generations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…